Erik Rodevand

Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis.

Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis.

Journal: Frontiers in medicine

Published: October 28, 2022

Effectiveness and Persistence in SB4- and Reference Etanercept-Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway.

Effectiveness and Persistence in SB4- and Reference Etanercept-Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway.

Journal: Arthritis care & research

Published: March 23, 2022

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.

Journal: BMC health services research

Published: October 20, 2021

Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register.

Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register.

Journal: Drugs & aging

Published: July 11, 2020

Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.

Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.

Journal: Seminars in arthritis and rheumatism

Published: February 09, 2019

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study.

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study.

Journal: RMD open

Published: July 22, 2018

Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.

Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.

Journal: Seminars in arthritis and rheumatism

Published: April 18, 2018

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.

Journal: Annals of the rheumatic diseases

Published: February 21, 2018

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.

Journal: Annals of the rheumatic diseases

Published: February 09, 2017

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.

Journal: BMJ (Clinical research ed.)

Published: August 18, 2016

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.

Journal: Annals of the rheumatic diseases

Published: July 29, 2016

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach.

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach.

Journal: RMD open

Published: July 15, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026